Literature DB >> 21541854

Putting risk into perspective: the US medical eligibility criteria for contraceptive use.

Kathryn M Curtis1, Naomi K Tepper, Polly A Marchbanks.   

Abstract

Unintended pregnancy remains a considerable problem in the United States, with health risks for both mother and infant. These risks may be increased among women with medical conditions, for whom pregnancy can lead to severe adverse outcomes. Highly effective and safe contraceptive methods are available to prevent unintended pregnancy. However, women with medical conditions and their providers also may be concerned about potential risks associated with contraceptive method use. Evidence-based guidance documents can be helpful tools for clinicians to efficiently use evidence and put risks into perspective. The US Medical Eligibility Criteria for Contraceptive Use, 2010, provides evidence-based recommendations for the safety of contraceptive use among women with medical conditions and other characteristics. While some contraceptive methods pose risks for some women, these must be considered in context and weighed against such considerations as the absolute risk of adverse events and the risks associated with pregnancy. Most women, even women with medical conditions, can safely use highly effective methods of contraception and promoting their use will further efforts to reduce unintended pregnancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21541854     DOI: 10.1007/s11154-011-9177-1

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  42 in total

1.  Medical barriers to access to family planning.

Authors:  J D Shelton; M A Angle; R A Jacobstein
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

Review 2.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2004-08       Impact factor: 3.375

Review 3.  Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.

Authors:  Kathryn M Curtis; Denise J Jamieson; Herbert B Peterson; Polly A Marchbanks
Journal:  Contraception       Date:  2010-03-29       Impact factor: 3.375

4.  Contraception in perimenopausal women with diabetes mellitus.

Authors:  Olga R Grigoryan; Elena E Grodnitskaya; Elena N Andreeva; Marina V Shestakova; Galina A Melnichenko; Ivan I Dedov
Journal:  Gynecol Endocrinol       Date:  2006-04       Impact factor: 2.260

5.  Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit.

Authors:  George F Sawaya; Janelle Guirguis-Blake; Michael LeFevre; Russell Harris; Diana Petitti
Journal:  Ann Intern Med       Date:  2007-12-18       Impact factor: 25.391

Review 6.  Surrogate end points in clinical research: hazardous to your health.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

Review 7.  Hormonal contraceptives for contraception in overweight or obese women.

Authors:  Laureen M Lopez; David A Grimes; Mario Chen-Mok; Carolyn Westhoff; Alison Edelman; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

8.  U S. Medical Eligibility Criteria for Contraceptive Use, 2010.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2010-06-18

Review 9.  The effects of unintended pregnancy on infant, child, and parental health: a review of the literature.

Authors:  Jessica D Gipson; Michael A Koenig; Michelle J Hindin
Journal:  Stud Fam Plann       Date:  2008-03

10.  Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologists' knowledge and attitudes.

Authors:  Tessa Madden; Jenifer E Allsworth; Katherine J Hladky; Gina M Secura; Jeffrey F Peipert
Journal:  Contraception       Date:  2009-09-16       Impact factor: 3.375

View more
  3 in total

Review 1.  Contraception and the obese woman.

Authors:  Elizabeth Reifsnider; Nonie Mendias; Yolanda Davila; Jennie Bever Babendure
Journal:  J Am Assoc Nurse Pract       Date:  2013-02-27       Impact factor: 1.165

Review 2.  Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.

Authors:  E Carmina
Journal:  J Endocrinol Invest       Date:  2013-02-27       Impact factor: 4.256

3.  A Web-Based Decision Tool to Improve Contraceptive Counseling for Women With Chronic Medical Conditions: Protocol For a Mixed Methods Implementation Study.

Authors:  Justine P Wu; Laura J Damschroder; Michael D Fetters; Brian J Zikmund-Fisher; Benjamin F Crabtree; Shawna V Hudson; Mack T Ruffin; Juliana Fucinari; Minji Kang; L Susan Taichman; John W Creswell
Journal:  JMIR Res Protoc       Date:  2018-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.